Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the antiviral efficacy of treatment with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks as measured by the proportion of subjects with sustained viral response 12 weeks after cessation of treatment (SVR12) • To evaluate the safety and tolerability of the treatment regimen
Inclusion criteria
- Chronic hepatitis C virus infection